Add office photos
Employer?
Claim Account for FREE
Gland Pharma
3.8
based on 1.2k Reviews
Company Overview
Company Locations
Working at Gland Pharma
Company Summary
Gland Pharma Limited is one of the best pharma companies in India. As a leading, best Indian pharmaceutical company they believe in Ethics, Excellence, and Efficacy.
Overall Rating
3.8/5
based on 1.2k reviews
3% below
industry average
Highly rated for
Work-life balance
Critically rated for
Salary
Work Policy
Work from office
91% employees reported
Monday to Friday
63% employees reported
Strict timing
52% employees reported
No travel
45% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
77 employees reported
Health insurance
53 employees reported
Office cab/shuttle
27 employees reported
Cafeteria
20 employees reported
View all benefits
HCL Healthcare
Rated 
4.5 for Work-Life Balance by our employees on AmbitionBox
4.5 for Work-Life Balance by our employees on AmbitionBox Success to our employee's well-being? A work-life balance that's simply unbeatable.
About Gland Pharma
Founded in1978 (47 yrs old)
India Employee Count1k-5k
Global Employee Count1k-5k
India HeadquartersHyderabad, Telangana, India
Office Locations
--
Websiteglandpharma.com
Primary Industry
Other Industries
Are you managing Gland Pharma's employer brand? To edit company information,
claim this page for free
Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities. We are focused on meeting diverse injectables needs with a stable supply of affordable and high-quality products. We have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.
Mission: To be a global injectables player, providing value-added total solutions.
Vision: Instill Ethics, Excellence and Efficacy in every product and strive to be a global leader.
We accomplish this through:
-Teamwork
-Commitment to Current Good Manufacturing practices
-Continual Improvement of QMS
-Continuing education and Training
Managing your company's employer brand?
Claim this Company Page for FREE
Gland Pharma Ratings
based on 1.2k reviews
Overall Rating
3.8/5
How AmbitionBox ratings work?
5
486
4
370
3
153
2
68
1
115
Category Ratings
3.8
Work-life balance
3.7
Job security
3.6
Skill development
3.6
Work satisfaction
3.5
Company culture
3.4
Promotions
3.3
Salary
Gland Pharma is rated 3.8 out of 5 stars on AmbitionBox, based on 1.2k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Gland Pharma
based on 1.1k reviews
3.7
Rated by 106 Women
Rated 3.7 for Work-life balance and 3.6 for Job security
3.8
Rated by 1k Men
Rated 3.8 for Work-life balance and 3.7 for Job security
Work Policy at Gland Pharma
based on 150 reviews in last 6 months
Work from office
91%
Hybrid
6%
Permanent work from home
3%
Gland Pharma Reviews
Top mentions in Gland Pharma Reviews
+ 5 more
Sun Pharmaceutical Industries
Join us and thrive in a company culture that inspires and empowers.
Compare Gland Pharma with Similar Companies
 |  Change Company | Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 3.8/5 based on 1.2k reviews | 4.0/5 based on 6.8k reviews | 4.0/5 based on 5.8k reviews  | 4.1/5 based on 6.9k reviews |
Highly Rated for | Work-life balance | Skill development Company culture Work-life balance | Salary Skill development Job security | Skill development Salary Work-life balance |
Critically Rated for | Salary | Promotions |  No critically rated category | No critically rated category |
Primary Work Policy | Work from office 91% employees reported | Work from office 74% employees reported | Work from office 82% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 3.7 Good rated by 106 women | 4.0 Good rated by 753 women | 4.0 Good rated by 442 women | 4.1 Good rated by 681 women |
Rating by Men Employees | 3.8 Good rated by 1k men | 4.1 Good rated by 5.7k men | 4.0 Good rated by 5k men | 4.1 Good rated by 5.8k men |
Job security | 3.7 Good | 3.5 Good | 3.8 Good | 3.7 Good |
View more
Gland Pharma Salaries
Gland Pharma salaries have received with an average score of 3.3 out of 5 by 1.2k employees.
Chemist
(453 salaries)
Unlock
₹1.6 L/yr - ₹5.3 L/yr
Junior Executive
(406 salaries)
Unlock
₹3.2 L/yr - ₹7 L/yr
Junior Chemist
(248 salaries)
Unlock
₹1.1 L/yr - ₹3.4 L/yr
Officer
(221 salaries)
Unlock
₹1.8 L/yr - ₹5.5 L/yr
Junior Officer
(209 salaries)
Unlock
₹1.3 L/yr - ₹4.2 L/yr
Deputy Chemist
(180 salaries)
Unlock
₹1.7 L/yr - ₹3.9 L/yr
Deputy Officer
(132 salaries)
Unlock
₹1.6 L/yr - ₹4.4 L/yr
Deputy Manager
(125 salaries)
Unlock
₹8.6 L/yr - ₹16.5 L/yr
Research Associate
(96 salaries)
Unlock
₹3 L/yr - ₹8.5 L/yr
Senior Chemist
(71 salaries)
Unlock
₹2.1 L/yr - ₹5.6 L/yr
Gland Pharma Interview Questions
Interview questions by designation
Top Gland Pharma interview questions and answers
Get interview-ready with top interview questions
Gland Pharma Jobs
Popular Designations Gland Pharma Hires for
Senior Executive
Create job alerts
Quality Controller
Create job alerts
Graduate Apprentice
Create job alerts
Current Openings
Gland Pharma News
View all
Gland Pharma Share Price Target 2025 2026 to 2030
- Hyderabad-based pharmaceutical company Gland Pharma supplies injectables to over sixty countries.
- Gland Pharma shares have seen both short-term and long-term investors, and the stock's performance is under close observation.
- The Gland Pharma Share Price Target for 2025 is predicted to be between INR 1,813 to INR 2,827.
- From 2026 to 2030, Gland Pharma's share price target is projected at a minimum of INR 2,318 and a maximum of INR 6,680.08 in 2030.
- Gland Pharma's competitors include Sun Pharma, CIPLA, Divis Labs, and Dr. Reddys Labs.
- Gland Pharma's share price history isn't very long, having been listed on the National Stock Exchange in 2020.
- On August 13th, 2021, the GLAND NSE stock hit its highest point of INR 4,287.
- Consulting expert advice for the stock market predictions is advisable, as the values provided in the article are based on predictions and may not be accurate.
- Investors would need to consider verified information from other sources to make informed decisions about their investments.
- The article includes the projected maximum and minimum prices for Gland Pharma share for every month in 2025 and year-wise projection for 2026 to 2030.
VIE Stories | 10 Feb, 2025
Tata Chemicals, Gland Pharma, Power Grid, Welspun Enterprises Shares React Post Q3 Results
- Tata Chemicals reported a net loss of Rs 53 crore in the third quarter.
- Gland Pharma's net profit advanced by 6.7% to Rs 205 crore.
- Power Grid's profit rose by 4.13% to Rs 3,861.63 crore.
- Welspun Enterprises' profit fell by 13.4% to Rs 77.5 crore.
Bloomberg Quint | 4 Feb, 2025
Stock Market Live: GIFT Nifty Trades Above 23,500 As Trump's Tariff Pause Triggers Global Recovery
- GIFT Nifty trades above 23,500 as Trump's tariff pause triggers global recovery.
- Tata Chemicals, Power Grid, and Gland Pharma will be in focus on Tuesday.
- NSE Nifty 50 and BSE Sensex settled in losses on Monday due to potential trade wars.
- Risk-off sentiment drove money out of domestic markets.
Bloomberg Quint | 4 Feb, 2025
Gland Pharma Q3 net up 7% at ₹205 crore
- Gland Pharma's consolidated net profit increased 7% at ₹205 crore in Q3 FY25.
- The total revenue of the company declined 10% at ₹1384 crore in the same quarter.
- The production issues at its French unit Cenexi had an impact on revenue.
- Gland Pharma remains focused on strategic partnerships and driving long-term value creation.
HinduBusinessLine | 3 Feb, 2025
Stock Market Today: All You Need To Know Going Into Trade On Feb. 3
- US stocks ended lower on Friday after the White House asserted that President Donald Trump plans to impose import duties on China, Mexico and Canada over the weekend.
- The greenback notched its best week since November with the Dollar Index rising 0.4%.
- The NSE Nifty 50 and the BSE Sensex ended the Budget day on a muted note as traders assessed the impact of announcements made by Finance Minister Nirmala Sitharaman.
- Foreign portfolio investors stayed net sellers of Indian equities for the 22nd straight session as they sold stocks worth Rs 1,327 crore.
- Domestic institutional investors were net buyers for the 33rd consecutive session as they mopped up equities worth Rs 824 crore.
- Major earnings to look out for include Divi's Laboratories, Tata Chemicals, KEC International, Gland Pharma, and Garden Reach Shipbuilders.
- Stocks to watch: Hero MotoCorp, Lupin, Coal India, Eicher Motors, KEI Industries, MOIL, Indian Bank, Globus Spirits, Quess Corp, Happient Minds Technologies, Vinati Organics.
- In bulk deals, Amazon sold 0.5% shares of Quess Corp.
- Nifty February futures fell 0.25% at a premium of 73 points.
- The Indian rupee closed flat against the US dollar on Friday at 86.62.
Bloomberg Quint | 3 Feb, 2025
Gland Pharma Gets 'Neutral' Upgrade From Nomura But Target Price Slashed — Here's Why
- Nomura has upgraded its rating on Gland Pharma Ltd. from 'reduce' to 'neutral', but cut its target price, after the firm's third quarter results showed a dip in US exports.
- The research firm slashed the target price to Rs 1,790, from the previous target of Rs 1,800 per share.
- Nomura predicts a stronger product mix for Gland Pharma, potentially boosting the company's gross margin year-on-year.
- Although Nomura has adjusted its earnings forecasts for Gland Pharma, reducing estimates for FY25, FY26, and FY27, the brokerage continues to forecast strong Ebitda margin expansion over the next few years.
Bloomberg Quint | 21 Jan, 2025
Gland Pharma's Hyderabad Facility Receives Establishment Inspection Report From USFDA
- Gland Pharma's Hyderabad Facility Receives Establishment Inspection Report From USFDA
- The establishment inspection report confirms the closure of the good manufacturing practices inspection.
- US FDA conducted the inspection at Gland Pharma's Pashamylaram facility in Hyderabad.
- The inspection concluded with three observations, unrelated to data integrity.
Bloomberg Quint | 18 Jan, 2025
NBCC, Torrent Power, Gland Pharma F&O Contracts To Start Trading From Jan. 31
- The futures and options contract of six securities, including NBCC (India) Ltd., Torrent Power Ltd., and Gland Pharma Ltd., will begin trading from Jan. 31.
- Castrol India Ltd., the Phoenix Mills Ltd., and Solar Industries India Ltd. will also be part of the derivative segment.
- The move aims to deepen market participation, enhance price discovery, and improve market liquidity.
- To be included in the derivatives segment, a stock must meet certain criteria, including a maximum market-wide position limit of Rs 300 crore.
Bloomberg Quint | 7 Jan, 2025
Gland Pharma Gets FDA Nod For Vitamin K Deficiency Treatment Drug
- Gland Pharma has received FDA approval for its vitamin K deficiency treatment drug.
- The drug, phytonadione injectable emulsion, is used to treat disorders caused by vitamin K deficiency.
- The product will be sold in single-dose ampules of 10 mg/ml and is bioequivalent to the reference listed drug by Hospira Inc.
- Gland Pharma expects to launch the drug through its marketing partners soon.
Bloomberg Quint | 11 Dec, 2024
Stock Market Live Updates: Stock to buy today: Bank of India (₹114) BUY
- Nifty 50 and Sensex show positive gains.
- Top gainers: Nifty PSU Bank, Nifty Media, and Nifty Metal.
- Top losers: Nifty Pharma and Nifty FMCG.
- Key news highlights: Ola Electric plans new stores, TVS Motor sells division, Gland Pharma gets US FDA approval, PFC Consulting establishes new subsidiary, Nazara Technologies acquires stake in Funky Monkeys.
HinduBusinessLine | 4 Dec, 2024
Powered by
Gland Pharma Offices
Compare Gland Pharma with
Biocon Limited
3.9
Zydus Lifesciences
4.1
Aurobindo Pharma
4.0
Lupin
4.2
Torrent Pharmaceuticals
3.9
DIVI'S Laboratories
3.7
Alembic Pharmaceuticals
4.0
Hetero
3.9
Abbott
4.1
Micro Labs
3.6
Ajanta Pharma
4.1
GlaxoSmithKline Pharmaceuticals
4.1
Biological E
4.2
Wockhardt
3.9
Granules India
3.8
Sanofi
4.2
Indoco Remedies
3.6
Unichem Laboratories
3.8
FDC
4.0
Fresenius Kabi
4.2
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Write a review
Share interview
Contribute salary
Add office photos
Companies Similar to Gland Pharma
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.8k reviews
Dr. Reddy's
Clinical Research, Pharma
4.0
• 6.8k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.9k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 6k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.8k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
DIVI'S Laboratories
Pharma
3.7
• 1.4k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.1k reviews
Gland Pharma FAQs
When was Gland Pharma founded?
Gland Pharma was founded in 1978. The company has been operating for 47 years primarily in the Pharma sector.
Where is the Gland Pharma headquarters located?
Gland Pharma is headquartered in Hyderabad, Telangana.
How many employees does Gland Pharma have in India?
Gland Pharma currently has more than 4,200+ employees in India. Research & Development department appears to have the highest employee count in Gland Pharma based on the number of reviews submitted on AmbitionBox.
Does Gland Pharma have good work-life balance?
Gland Pharma has a Work-Life Balance Rating of 3.8 out of 5 based on 1,100+ employee reviews on AmbitionBox. 72% employees rated Gland Pharma 4 or above, while 28% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Gland Pharma work-life balance reviews for more details
Is Gland Pharma good for career growth?
Career growth at Gland Pharma is rated as moderate, with a promotions and appraisal rating of 3.4. 28% employees rated Gland Pharma 3 or below, while 72% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Gland Pharma promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Gland Pharma?
Working at Gland Pharma comes with several advantages and disadvantages. It is highly rated for work life balance. However, it is poorly rated for salary & benefits, based on 1,100+ employee reviews on AmbitionBox.
Recently Viewed
PHOTOS
Medanta the Medicity
4 office photos
COMPANY BENEFITS
Micromax Informatics
No Benefits
SALARIES
Sanofi
No Salaries
SALARIES
FMC Corporation
COMPANY BENEFITS
Sanofi
No Benefits
REVIEWS
Samsung
No Reviews
REVIEWS
Samsung
No Reviews
SALARIES
ITC
SALARIES
FMC Corporation
SALARIES
FMC Corporation
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
